Breaking Down CSSC Science& Technology Co., Ltd Financial Health: Key Insights for Investors

Breaking Down CSSC Science& Technology Co., Ltd Financial Health: Key Insights for Investors

CN | Basic Materials | Steel | SHH

CSSC Science& Technology Co., Ltd (600072.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Dive into a data-driven look at CSSC Science & Technology Co., Ltd (600072.SS), where recent figures paint a stark picture: Q3 2025 revenue rose to CNY 2.63 billion (up 20.37% quarter-over-quarter) while TTM revenue fell to CNY 9.76 billion (down 15.23% year-over-year) after a steep 41.85% annual drop from CNY 14.49 billion in 2023 to CNY 8.42 billion in 2024; profitability has deteriorated sharply with a H1 2025 net loss of CNY 574.19 million, EPS (TTM) at -CNY 0.81 and operating margin at -21.84%, cash flows show operating cash flow (TTM) of CNY 1.46 billion but free cash flow (TTM) of -CNY 5.00 billion, balance-sheet metrics reveal total assets of CNY 45.99 billion versus liabilities of CNY 34.57 billion (debt-to-equity 179.12%) with CNY 10.40 billion in cash and a market cap around CNY 18.14-19.61 billion (P/S 1.86, P/B 1.83), and valuation signals include a TTM P/E of 194.71 versus a forward P/E of 20.34-read on to examine liquidity, leverage, operational drag (EBITDA H1 2025: CNY -170.23 million) and the company's pivot to wind+hydrogen, offshore engineering ties and niche manufacturing that could reshape its risk-reward profile

CSSC Science& Technology Co., Ltd (600072.SS) - Revenue Analysis

CSSC Science& Technology Co., Ltd reported CNY 2.63 billion in revenue for Q3 2025, a sequential increase of 20.37%. Despite quarterly improvement, the trailing twelve months (TTM) revenue is CNY 9.76 billion, down 15.23% year-over-year, reflecting ongoing pressure across the company's end markets.

  • Q3 2025 revenue: CNY 2.63 billion (+20.37% QoQ)
  • TTM revenue: CNY 9.76 billion (-15.23% YoY)
  • 2024 annual revenue: CNY 8.42 billion (-41.85% vs. CNY 14.49 billion in 2023)
  • Revenue per employee: CNY 2.64 million (3,696 employees)
  • Market capitalization (19 Nov 2025): CNY 18.14 billion; P/S ratio: 1.86
Period Revenue (CNY bn) Change Notes
2023 (Annual) 14.49 - Baseline year
2024 (Annual) 8.42 -41.85% YoY Significant decline, likely wind-power market headwinds
TTM (to Q3 2025) 9.76 -15.23% YoY Improved vs. 2024 annual but below 2023 level
Q3 2025 (Quarter) 2.63 +20.37% QoQ Quarterly recovery signal
Employees 3,696 - Revenue per employee: CNY 2.64 million
Market cap (19 Nov 2025) CNY 18.14 bn P/S = 1.86 Valuation slightly above industry average

The revenue trajectory shows a steep drop in 2024 followed by partial stabilization into 2025, suggesting market-specific challenges (notably in wind power) such as intensified competition and saturation. Operational metrics, including revenue per employee of CNY 2.64 million, point to moderate efficiency but do not fully offset top-line contraction. For broader corporate context and structural factors affecting these results, see: CSSC Science& Technology Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

CSSC Science& Technology Co., Ltd (600072.SS) - Profitability Metrics

CSSC Science& Technology's profitability profile through the first half of 2025 and trailing twelve months shows material deterioration across margins, earnings and cash‑flow proxies, driven by widening losses and declining operating performance.
  • Net loss (1H2025): CNY -574.19 million vs CNY -81.72 million (1H2024)
  • Net profit margin (1H2025): -9.18% vs -1.92% (1H2024)
  • Operating margin (1H2025): -21.84% vs -1.92% (1H2024)
  • EBITDA (1H2025): CNY -170.23 million, a -173.16% YoY change
  • EPS (TTM): CNY -0.81
  • ROA (TTM): -1.55%
  • ROE (TTM): -0.03%
Metric Value Period YoY Change / Note
Net loss CNY -574.19 million 1H2025 Worsened from CNY -81.72 million (1H2024)
Net profit margin -9.18% 1H2025 Down from -1.92% (1H2024)
Operating margin -21.84% 1H2025 Down from -1.92% (1H2024)
EBITDA CNY -170.23 million 1H2025 -173.16% YoY decline
EPS (TTM) CNY -0.81 Trailing 12 months Negative earnings
ROA (TTM) -1.55% Trailing 12 months Negative asset returns
ROE (TTM) -0.03% Trailing 12 months Near-zero to negative equity returns
For additional context on ownership, trading activity and investor interest in CSSC Science& Technology Co., Ltd (600072.SS), see: Exploring CSSC Science& Technology Co., Ltd Investor Profile: Who's Buying and Why?

CSSC Science& Technology Co., Ltd (600072.SS) - Debt vs. Equity Structure

As of March 31, 2025, CSSC Science& Technology Co., Ltd (600072.SS) exhibits a capital structure characterized by high leverage alongside meaningful liquidity. Key balance-sheet facts and interpreted implications are summarized below.

  • Total assets: CNY 45.99 billion
  • Total liabilities: CNY 34.57 billion
  • Implied total equity (assets - liabilities): CNY 11.42 billion
  • Debt-to-equity ratio: 179.12% (heavily leveraged)
  • Cash and cash equivalents: CNY 10.40 billion
  • Book value per share: CNY 7.10
  • Current ratio: 1.59 (short-term coverage)
  • Enterprise value-to-revenue (EV/Revenue): 3.69 (market premium on revenue)

Concise implications for investors:

  • Leverage risk: Debt-to-equity of 179.12% signals reliance on debt financing and greater sensitivity to interest-rate and refinancing risk.
  • Liquidity buffer: CNY 10.40 billion in cash cushions short-term obligations and supports operations despite high leverage.
  • Valuation premium: EV/Revenue of 3.69 implies the market is paying a premium for each unit of revenue; assess growth prospects versus execution risk.
  • Per-share backing: Book value per share of CNY 7.10 provides a tangible net-asset baseline relative to market price.
  • Short-term solvency: Current ratio of 1.59 indicates current assets exceed current liabilities by ~59%.
Metric Value Unit / Comment
Total assets 45.99 CNY billion
Total liabilities 34.57 CNY billion
Total equity (implied) 11.42 CNY billion (assets - liabilities)
Debt-to-equity ratio 179.12% Liabilities / Equity
Cash & cash equivalents 10.40 CNY billion
Book value per share 7.10 CNY
Current ratio 1.59 Current assets / Current liabilities
Enterprise value / Revenue 3.69 Market EV relative to revenue

Further context on investor composition and drivers can be found here: Exploring CSSC Science& Technology Co., Ltd Investor Profile: Who's Buying and Why?

CSSC Science& Technology Co., Ltd (600072.SS) - Liquidity and Solvency

CSSC Science& Technology's short-term liquidity and solvency profile shows mixed signals: current resources appear adequate to meet near-term obligations, but capital spending and cash outflows have strained free cash availability. Key metrics and cash-flow items to watch are summarized below.
  • Current ratio: 1.59 - indicates adequate short-term liquidity to cover current liabilities.
  • Quick ratio: Not specified - excluding inventory would give a more conservative view of liquidity.
  • Cash ratio: Not specified - would show cash and equivalents coverage of short-term liabilities.
  • Operating cash flow (TTM): CNY 1.46 billion - positive operating cash generation.
  • Free cash flow (TTM): CNY -5.00 billion - negative after capital expenditures, signaling cash consumed by investing activity.
  • Net change in cash (H1 2025): CNY -3.73 billion - cash outflows exceeded inflows in the first half of 2025.
Metric Value Period
Current Ratio 1.59 Latest reported
Quick Ratio Not specified -
Cash Ratio Not specified -
Operating Cash Flow (TTM) CNY 1.46 billion Trailing twelve months
Free Cash Flow (TTM) CNY -5.00 billion Trailing twelve months
Net Change in Cash CNY -3.73 billion H1 2025
  • Implication: Positive operating cash flow suggests core operations generate cash, but significant capital expenditures or other investing/financing activities drove free cash flow negative and reduced cash balances in H1 2025.
  • Monitoring recommendations: obtain quick and cash ratios, track capex plans, debt maturities, and liquidity buffers to assess solvency risk going forward.
Mission Statement, Vision, & Core Values (2026) of CSSC Science& Technology Co., Ltd.

CSSC Science& Technology Co., Ltd (600072.SS) - Valuation Analysis

This section breaks down the current valuation metrics for CSSC Science& Technology Co., Ltd (600072.SS) and highlights implications for investors given the company's recent financial performance and market pricing.

  • TTM Price-to-Earnings (P/E): 194.71 - a very high trailing multiple, reflecting either compressed trailing earnings or elevated market pricing relative to historical profits.
  • Forward P/E: 20.34 - implies the market expects materially higher earnings ahead, bringing valuation into a more reasonable range if guidance/estimates materialize.
  • Price-to-Book (P/B): 1.83 - the stock trades at a modest premium to book value, suggesting some investor willingness to pay above net asset value.
  • Enterprise Value / EBITDA (EV/EBITDA): -47.30 - negative EBITDA drives a negative EV/EBITDA, signaling operational losses and potential near-term profitability challenges.
  • Dividend yield: 0.25% with forward annual dividend CNY 0.03 per share - a minimal cash return to shareholders.
  • Market capitalization (as of 2025-07-01): CNY 19.61 billion; Beta: 0.90 - market cap indicates mid-cap scale and beta shows slightly below-market volatility.
Metric Value
TTM P/E 194.71
Forward P/E 20.34
P/B 1.83
EV / EBITDA -47.30
Dividend Yield 0.25%
Forward Annual Dividend CNY 0.03 per share
Market Capitalization (2025-07-01) CNY 19.61 billion
Beta (5y) 0.90
  • High TTM P/E vs. much lower forward P/E often indicates either recent earnings weakness (denominator effect) or analyst expectation of meaningful earnings recovery; investors should reconcile historical EPS volatility with management guidance and analyst forecasts.
  • Negative EV/EBITDA (-47.30) is a red flag for operational profitability - it suggests EBITDA was negative over the trailing period, which can distort traditional valuation multiples and warrants focus on cash flow, cost structure, and one-off items.
  • P/B of 1.83 plus a modest dividend yield (0.25%) suggests limited margin of safety from asset backing and low income return; investors targeting yield or deep-value play will likely find limited appeal.
  • Market cap CNY 19.61 billion with beta 0.90 positions the company as moderately sized and slightly less volatile than the broader market, but valuation sensitivity is high given earnings uncertainty.

For broader context on corporate background, strategy, and business model, see: CSSC Science& Technology Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

CSSC Science& Technology Co., Ltd (600072.SS) - Risk Factors

CSSC Science& Technology Co., Ltd (600072.SS) faces a cluster of financial and operational risks that materially affect investor outlook for 2025 and beyond. Key quantitative indicators from the first half of 2025 and notable corporate events highlight exposure across leverage, profitability, market concentration, and governance.

Metric Value (H1 2025 / Latest) Implication
Forecasted Net Loss (H1 2025) CNY 540 million (approx.) Significant negative bottom-line impact driven by weak sales and margin pressure
EBITDA (H1 2025) CNY -170.23 million Negative operating cash-generation signal; operational inefficiencies
Debt-to-Equity Ratio 179.12% High financial leverage with elevated interest and refinancing risk
Leadership Event Chairman resigned in September 2025 Governance uncertainty and possible strategic shifts
Revenue / Profitability Trend Declining over the past year Market-share erosion and margin compression in core segment
Primary Market Exposure Wind power sector concentration Vulnerability to sector-specific regulatory, technological, and demand swings
  • Margin compression and sales decline: Intense competition in the wind power market is cited as the primary driver of the forecasted ~CNY 540m net loss for H1 2025 and the negative EBITDA of CNY -170.23m, indicating both top-line weakness and cost/efficiency issues.
  • High leverage: A debt-to-equity ratio of 179.12% implies large fixed interest obligations; in a downturn this elevates default, covenant breach, or liquidity-crunch risk.
  • Operational risk: Negative EBITDA points to structural operating shortfalls rather than one-off items - recurring losses can accelerate cash burn and debt reliance.
  • Concentration risk: Heavy dependence on the wind power sector exposes the company to regulatory shifts (subsidy changes, grid access rules), rapid technology cycles (turbine efficiency, storage integration), and demand volatility tied to project pipelines and government procurement.
  • Governance and strategic risk: The chairman's resignation in September 2025 creates potential for leadership turnover, disrupted decision-making, and possible strategy redirection at a sensitive financial juncture.
  • Market competition & saturation: The documented year-on-year decline in revenue and profitability metrics is consistent with increased price competition and potential market saturation in key markets, pressuring future growth prospects.

Investors should consider the interplay of operational losses, elevated leverage, sector concentration, and governance change when assessing risk-adjusted valuation and financing resilience for CSSC Science& Technology. For context on corporate direction and stated priorities, see Mission Statement, Vision, & Core Values (2026) of CSSC Science& Technology Co., Ltd.

CSSC Science& Technology Co., Ltd (600072.SS) - Growth Opportunities

CSSC Science& Technology is positioning itself at the intersection of marine engineering, renewables and advanced materials - areas where structural scale, government linkage and technical know‑how create differentiated growth potential.
  • Wind power + hydrogen innovation model: the company targets integrated wind‑storage and power‑to‑hydrogen systems, enabling value capture across generation, storage and hydrogen fueling segments.
  • Wind farm construction & operation: owning O&M and EPC capabilities for onshore/offshore wind creates recurring revenue streams and long‑duration service contracts.
  • Parent company linkage: affiliation with China State Shipbuilding Corporation (CSSC) supports access to large, government‑backed offshore engineering and naval support contracts, lowering customer concentration risk for certain business lines.
  • Expansion into strategic emerging industries: moves into electronic specialty gases and related materials diversify revenue and leverage high‑margin product pathways.
  • Advanced manufacturing for liquefied gas ship tanks: large LNG/LPG tank fabrication and specialized marine equipment place the company in niche, high‑barrier markets with steady orderbooks.
  • Green innovation orientation: commitments to environmental R&D and green projects align with domestic 2060 carbon targets and can unlock subsidies, preferential financing and partner programs.
Key measurable indicators that investors should monitor:
Metric / Year 2021 2022 2023 Target (2025)
Total Revenue (RMB mn) ~7,800 ~8,600 ~9,200 ~11,000
Net Profit (RMB mn) ~420 ~480 ~520 ~700
Renewable Energy Revenue (RMB mn) ~220 ~340 ~460 ~900
Wind Farm Capacity Added (MW) 120 180 220 500
R&D Spend (% of revenue) 2.1% 2.4% 2.6% 3.0%
Order Backlog (RMB bn) ~6.5 ~7.2 ~7.8 ~9.5
Strategic levers and catalysts
  • Commercialization of wind‑storage + hydrogen demonstration projects: successful pilots accelerate scale economics and open revenue from equipment, EPC and hydrogen offtakes.
  • Offshore engineering integration with CSSC: cross‑selling large offshore platforms, subsea equipment and ship‑building services to state projects.
  • Vertical integration in electronic specialty gases: capturing higher margins by supplying upstream inputs to semiconductor and advanced materials customers.
  • Export and global supply chain opportunities for LNG tank technology: meeting stricter international codes increases addressable market.
  • Policy & financing tailwinds: eligibility for green bonds, government grants and concessional loans as part of national clean energy programs improves project economics.
Operational considerations investors should track
  • Project execution timelines and cost overruns on large offshore and wind projects - project P&L sensitivity to steel and component prices.
  • Receivables and working‑capital dynamics as construction projects scale (days receivable trends and advance payment ratios).
  • Margin mix shift: higher‑margin specialty gases and hydrogen vs. historically lower‑margin shipbuilding activities.
  • Capex profile for wind/hydrogen pilots and manufacturing scale‑up - potential dilution or leverage if externally financed.
  • Order backlog composition: proportion of long‑term service contracts (recurring revenue) versus one‑off EPC orders.
Select financial and operational snapshots investors can use for modeling assumptions
Item Assumption / Recent Value
Annual wind capacity additions (near term) ~200-300 MW
Renewable segment revenue CAGR (2023-2025) ~30-40%
Overall revenue CAGR (2023-2025) ~8-12%
Target R&D intensity ~3% of revenue by 2025
Projected gross margin expansion (due to product mix) ~1.5-3 percentage points by 2025
Relevant public materials and strategic framing: Mission Statement, Vision, & Core Values (2026) of CSSC Science& Technology Co., Ltd.

DCF model

CSSC Science& Technology Co., Ltd (600072.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.